Incidence and outcome of pancreatitis in children and young adults with acute lymphoblastic leukaemia treated on a contemporary protocol, UKALL 2003.

Incidence and outcome of pancreatitis in children and young adults with acute lymphoblastic leukaemia treated on a contemporary protocol, UKALL 2003.

Mostrar outras versões (1)

Detalhes bibliográficos
Principais autores:	Samarasinghe, S, Dhir, S, Slack, J, Iyer, P, Wade, R, Clack, R, Vora, A, Goulden, N
Formato:	Journal article
Idioma:	English
Publicado em:	2013

Registros relacionados

Incidence and outcome of pancreatitis in children and young adults with acute lymphoblastic leukaemia treated on a contemporary protocol, UKALL 2003
por: Samarasinghe, S, et al.
Publicado em: (2013)

Down Syndrome is a significant risk factor for infectious deaths in childhood acute lymphoblastic leukaemia: a retrospective analysis of the infectious deaths on UKALL 2003
por: O'Connor, D, et al.
Publicado em: (2014)

Infection-related mortality in children with acute lymphoblastic leukemia: an analysis of infectious deaths on UKALL2003.
por: O'Connor, D, et al.
Publicado em: (2014)

Outcome for children and young people with Early T-cell precursor acute lymphoblastic leukaemia treated on a contemporary protocol, UKALL 2003
por: Patrick, K, et al.
Publicado em: (2014)

Outcome for children and young people with Early T-cell precursor acute lymphoblastic leukaemia treated on a contemporary protocol, UKALL 2003.
por: Patrick, K, et al.
Publicado em: (2014)

Improved Outcome for Children and Young Adults with T-Cell Acute Lymphoblastic Leukaemia (ALL): Results of the United Kingdom Medical Research Council (MRC) Trial UKALL 2003
por: Vora, A, et al.
Publicado em: (2008)

Efficacy and Toxicity of Pegylated Asparaginase in the Treatment of Children and Young Adults with Acute Lymphoblastic Leukaemia: Results of the United Kingdom Medical Research Council (MRC) Trial UKALL 2003
por: Vora, A, et al.
Publicado em: (2008)

Treatment reduction for children and young adults with low-risk acute lymphoblastic leukaemia defined by minimal residual disease (UKALL 2003): a randomised controlled trial.
por: Vora, A, et al.
Publicado em: (2013)

Treatment reduction for children and young adults with low-risk acute lymphoblastic leukaemia defined by minimal residual disease (UKALL 2003): a randomised controlled trial
por: Vora, A, et al.
Publicado em: (2013)

UKALL 2003, A Randomised Trial Investigating Treatment Reduction for Children and Young Adults with Minimal Residual Disease Defined Low Risk Acute Lymphoblastic Leukaemia
por: Vora, A, et al.
Publicado em: (2010)

UKALL 2003, A Randomised Trial Investigating Treatment Reduction for Children and Young Adults with Minimal Residual Disease Defined Low Risk Acute Lymphoblastic Leukaemia
por: Vora, A, et al.
Publicado em: (2010)

UKALL 2003, A Randomised Trial Investigating Treatment Reduction for Children and Young Adults with Minimal Residual Disease Defined Low Risk Acute Lymphoblastic Leukaemia
por: Vora, A, et al.
Publicado em: (2010)

PROSPECTIVE EVALUATION OF QUALITY OF LIFE (QOL) IN CHILDREN TREATED IN UKALL 2003 FOR ACUTE LYMPHOBLASTIC LEUKAEMIA (ALL): A COHORT STUDY
por: Eiser, C, et al.
Publicado em: (2012)

Prospective evaluation of quality of life in children treated in UKALL 2003 for Acute Lymphoblastic Leukaemia (ALL): A cohort study
por: Eiser, C, et al.
Publicado em: (2017)

Post-Remission MRD Kinetics in Children with Acute Lymphoblastic Leukaemia Receiving Augmented BFM Consolidation Compared with Other Regimens Results of the Medical Research Council Trial UKALL2003.
por: Cutting, R, et al.
Publicado em: (2008)

Augmented post-remission therapy for a minimal residual disease-defined high-risk subgroup of children and young people with clinical standard-risk and intermediate-risk acute lymphoblastic leukaemia (UKALL 2003): a randomised controlled trial.
por: Vora, A, et al.
Publicado em: (2014)

Augmented post-remission therapy for a minimal residual disease-defined high-risk subgroup of children and young people with clinical standard-risk and intermediate-risk acute lymphoblastic leukaemia (UKALL 2003): A randomised controlled trial
por: Vora, A, et al.
Publicado em: (2014)

Incidence and Outcome of Osteonecrosis in Children and Young Adults with Acute Lymphoblastic Leukaemia Treated on a Dexamethasone Containing Protocol: Results of the Medical Research Council UK Trial ALL 2003
por: Vora, A, et al.
Publicado em: (2008)

Characteristics and outcome of children and young adults with Early T-Precursor (ETP) ALL treated on UKALL 2003
por: Patrick, K, et al.
Publicado em: (2013)

Post-remission MRD kinetics in children with acute lymphoblastic leukaemia receiving augmented BFM consolidation compared with other regimens: update of results of the Medical Research Council Trial UKALL2003
por: Cutting, R, et al.
Publicado em: (2009)

Outcome of Thrombosis in UKALL 2003-Anticoagulation and Re-Exposure to Aspariginase Is Feasible and Safe.
por: Qureshi, A, et al.
Publicado em: (2008)

UKALL 2003, A Randomised Trial Investigating Treatment Intensification for Children and Young Adults with Minimal Residual Disease Defined High Risk Acute Lymphoblastic Leukaema
por: Vora, A, et al.
Publicado em: (2012)

High incidence of avascular necrosis in adolescents with acute lymphoblastic leukaemia: a UKALL XII analysis.
por: Patel, B, et al.
Publicado em: (2008)

Outcome of Down syndrome associated acute lymphoblastic leukaemia treated on a contemporary protocol.
por: Patrick, K, et al.
Publicado em: (2014)

Outcome of Down syndrome associated acute lymphoblastic leukaemia treated on a contemporary protocol
por: Patrick, K, et al.
Publicado em: (2014)

Impact of NOTCH1/FBXW7 mutations on outcome in pediatric T-cell acute lymphoblastic leukemia patients treated on the MRC UKALL 2003 trial.
por: Jenkinson, S, et al.
Publicado em: (2013)

No association of HLA-A supertype with outcome in childhood acute lymphoblastic leukaemia: results of the UKALL XI trial.
por: Thompson, P, et al.
Publicado em: (2011)

Asparaginase-related venous thrombosis in UKALL 2003- re-exposure to asparaginase is feasible and safe.
por: Qureshi, A, et al.
Publicado em: (2010)

Profile of Steroid Toxicity During Maintenance Treatment in Teenage and Young Adult (TYA) Patients with Acute Lymphoblastic Leukaemia (ALL)
por: Tomlins, J, et al.
Publicado em: (2012)

Gender and treatment outcome in childhood lymphoblastic leukaemia: report from the MRC UKALL trials.
por: Chessells, J, et al.
Publicado em: (1995)

Genotype-specific MRD interpretation improves stratification in paediatric acute lymphoblastic leukaemia
por: O'Connor, D, et al.
Publicado em: (2017)

Cytogenetics and prognosis in childhood lymphoblastic leukaemia: results of MRC UKALL X. Medical Research Council Working Party in Childhood Leukaemia.
por: Chessels, J, et al.
Publicado em: (1997)

Treatment related deaths during induction and in first remission in acute lymphoblastic leukaemia: MRC UKALL X.
por: Wheeler, K, et al.
Publicado em: (1996)

Continuing (maintenance) therapy in lymphoblastic leukaemia: lessons from MRC UKALL X. Medical Research Council Working Party in Childhood Leukaemia.
por: Chessells, J, et al.
Publicado em: (1997)

Acute lymphoblastic leukaemia in infancy: experience in MRC UKALL trials. Report from the Medical Research Council Working Party on Childhood Leukaemia.
por: Chessells, J, et al.
Publicado em: (1994)

Comparison of allogeneic transplant versus chemotherapy for relapsed childhood acute lymphoblastic leukaemia in the MRC UKALL R1 trial
por: Harrison, G, et al.
Publicado em: (2000)

Failure of a new protocol to improve treatment results in paediatric lymphoblastic leukaemia: lessons from the UK Medical Research Council trials UKALL X and UKALL XI.
por: Chessells, J, et al.
Publicado em: (2002)

Bone marrow transplantation for high-risk childhood lymphoblastic leukaemia in first remission: experience in MRC UKALL X.
por: Chessells, J, et al.
Publicado em: (1992)

Influence of HLA-DP supertype on the survival of childhood acute lymphoblastic leukaemia: analysis of the UKALL X1 trial
por: Taylor, G, et al.
Publicado em: (2008)

Comparison of bone marrow transplant and chemotherapy for relapsed childhood acute lymphoblastic leukaemia: the MRC UKALL X experience
por: Wheeler, K, et al.
Publicado em: (1998)